Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Ferring Pharmaceuticals Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (43)
Cancellation by sponsor (27)
Australian Public Assessment Report (AusPAR) (11)
Prescription medicine registration (1)
Section 14, TGO91 consent (1)

Date

2024 (2)
2022 (9)
2021 (2)
2020 (13)
2019 (4)
2018 (3)
2017 (6)
2016 (3)
2015 (5)
2014 (2)
2013 (1)
2012 (5)
2011 (3)
2010 (3)
2009 (2)
2007 (8)
2004 (3)
2003 (4)
2002 (1)
1997 (1)
1994 (2)
1992 (1)

Results for "[search-keyword]"

Search

Sponsor content

83 result(s) found, displaying 11 to 20

Ferring Pharmaceuticals Pty Ltd - Wet wipe Cancelled under Section 41GL(d) of the Act

18 March 2022

Cancellation by sponsor

Requested by Ferring Pharmaceuticals Pty Ltd
Ferring Pharmaceuticals Pty Ltd - Pharmaceutical management support software Cancelled under Section 41GL(d) of the Act

8 October 2021

Cancellation by sponsor

Requested by Ferring Pharmaceuticals Pty Ltd
MINIRIN desmopressin acetate 0.1mg/mL nasal drops bottle Cancelled under Section 30(1)(c) of the Act

1 June 2021

Cancellation by sponsor

Requested by Ferring Pharmaceuticals Pty Ltd
KLYX enema bottle Cancelled under Section 30(1)(c) of the Act

14 December 2020

Cancellation by sponsor

Requested by Ferring Pharmaceuticals Pty Ltd
Ferring Pharmaceuticals Pty Ltd - Adaptor, syringe/needle Cancelled under Section 41GL(d) of the Act

14 December 2020

Cancellation by sponsor

Requested by Ferring Pharmaceuticals Pty Ltd
Ferring Pharmaceuticals Pty Ltd - Injector, medication/vaccine, needleless, mechanically-powered Cancelled under Section 41GL(d) of the Act

14 December 2020

Cancellation by sponsor

Requested by Ferring Pharmaceuticals Pty Ltd
ZOMACTON somatropin 4mg multidose powder for injection vial with diluent vial Cancelled under Section 30(1)(c) of the Act

14 December 2020

Cancellation by sponsor

Requested by Ferring Pharmaceuticals Pty Ltd
ZOMACTON somatropin 10mg multidose powder for injection vial with diluent syringe Cancelled under Section 30(1)(c) of the Act

14 December 2020

Cancellation by sponsor

Requested by Ferring Pharmaceuticals Pty Ltd
ZOMACTON somatropin 4mg multidose powder for injection vial with diluent ampoule Cancelled under Section 30(1)(c) of the Act

14 December 2020

Cancellation by sponsor

Requested by Ferring Pharmaceuticals Pty Ltd
REKOVELLE follitropin delta (rhu) 12 microgram/0.36 mL solution for injection glass cartridge with rubber plunger Cancelled under Section 30(1)(c) of the Act

14 December 2020

Cancellation by sponsor

Requested by Ferring Pharmaceuticals Pty Ltd

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.